✦ LIBER ✦

Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS)

✍ Scribed by David A. Morrow; Marc S. Sabatine; Elliott M. Antman; Christopher P. Cannon; Eugene Braunwald; Pierre Theroux

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlates of Bleeding Events Among Mode

✍ Ajay J. Kirtane; Gregory Piazza; Sabina A. Murphy; Daniela Budiu; David A. Morro 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Downstream administration of a high-dose

✍ Gian B. Danzi; Marco Sesana; Cinzia Capuano; Luigi Mauri; Simonetta Predolini; R 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Benefit of standard versus low-dose tiro

✍ Lin, Yun-ling; Chen, Liang-long; Luo, Yu-kun; Zheng, Xing-chun; Li, Wei-wei 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 Chinese ⚖ 472 KB

THE USE OF HEMODYNAMIC SUPPORT IN OCTOGE

✍ Fraij, Ghassan; Massaro, Joseph; David, Shukri; Kleiman, Neal; Denktas, Ali; Dix 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Incidence of true clopidogrel resistance

✍ M Bedossa; V Letocart; P Gueret; G Leurent; D Boulmier; H Le Breton 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Intracoronary versus intravenous high-do

✍ Basar Candemir, Mustafa Kilickap, Ozgur Ulas Ozcan, Cansin Tulunay Kaya, Menekse 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 197 KB